نتایج جستجو برای: rilpivirine

تعداد نتایج: 396  

Journal: :Journal of the American Chemical Society 2013
Won-Gil Lee Ricardo Gallardo-Macias Kathleen M Frey Krasimir A Spasov Mariela Bollini Karen S Anderson William L Jorgensen

Members of the catechol diether class are highly potent non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs). The most active compounds yield EC50 values below 0.5 nM in assays using human T-cells infected by wild-type HIV-1. However, these compounds such as rilpivirine, the most recently FDA-approved NNRTI, bear a cyanovinylphenyl (CVP) group. This is an uncommon substructure in d...

2017
Jesús Troya Pablo Ryan Esteban Ribera Daniel Podzamczer Victor Hontañón Jose Alberto Terrón Vicente Boix Santiago Moreno Pilar Barrufet Manuel Castaño Ana Carrero María José Galindo Ignacio Suárez-Lozano Hernando Knobel Miguel Raffo Javier Solís María Yllescas Herminia Esteban Juan González-García Juan Berenguer Arkaitz Imaz

[This corrects the article DOI: 10.1371/journal.pone.0164455.].

Journal: :Sexually Transmitted Infections 2020

2016
Nitin Charbe Sara Baldelli Valeria Cozzi Simone Castoldi Dario Cattaneo Emilio Clementi

A new method using high-performance liquid chromatography coupled with ultra violet detection (HPLC-UV) was developed and validated for the simultaneous quantification of atazanavir, dolutegravir, darunavir, efavirenz, etravirine lopinavir, raltegravir, rilpivirine and tipranavir in human plasma. For the first time we reported here the development and validation of an HPLC-UV assay to quantify ...

Journal: :European Journal of Case Reports in Internal Medicine 2023

Long-acting (LA) cabotegravir/rilpivirine (CAB/RPV) is a complete regimen for the management of human immunodeficiency virus type 1 (HIV-1) infection to replace their oral antiretroviral therapy (ART) when they have been virologically suppressed. We present case successful achievement undetectable HIV RNA viral load levels in an acquired syndrome (AIDS) patient with long-standing virologic fail...

Journal: :The new microbiologica 2017
Stefano Rusconi Simone Marcotullio Antonella Cingolani

Current cART regimens are highly potent and well tolerated, but long-term toxicities, drug-drug interactions, lifetime costs and scarce option for multiclass failed patients could limit the efficacy of treatment itself. Long-acting formulations of antiretrovirals, which could potentially replace daily tablets, have been developed and are under investigation for prevention and treatment of HIV i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید